Remember when they told you Ivermectin was “horse paste”? Remember the sneering late-night hosts, the Facebook fact-checkers slapping warning labels on your posts, the pharmacists who refused to fill legitimate prescriptions? Remember how the entire medical establishment locked arms and declared that anyone who even whispered the word “Ivermectin” was a knuckle-dragging conspiracy theorist who probably thought 5G towers caused rashes?
Good. Hold that memory. Because science just kicked the door down.
The Study They Don’t Want You to See
Dr. Peter McCullough and his team at The Wellness Company just dropped a first-of-its-kind human observational study on a combination of Ivermectin and Mebendazole — two Nobel Prize-recognized, FDA-approved compounds — and the results are enough to make Big Pharma choke on its quarterly earnings report.
Out of 122 cancer patients who completed a six-month follow-up, 84.4% reported a clinical benefit. That means no evidence of disease, tumor shrinkage, or stable disease. Nearly half — 48.4% — reported the strongest possible outcomes: tumors shrinking or no current evidence of disease at all. And 86.9% completed their initial prescription, with most side effects described as mild.
Read those numbers again. Slowly. Now ask yourself why you’re not hearing about this on CNN.
How It Works — And Why It’s Cheap
Here’s the part that makes pharmaceutical executives reach for the Tums. The dual mechanism is elegant in its simplicity: Ivermectin disrupts tumor growth pathways and triggers cancer cell death — that’s apoptosis for the science crowd. Mebendazole blocks glucose uptake, essentially starving the abnormal cells. Combined into a single compounded capsule, it’s a protocol real patients actually followed and completed.
These aren’t experimental mystery drugs cooked up in some Silicon Valley biolab. They’re widely available, low-cost medications that have been used safely for decades. And that’s exactly the problem — for the people who profit from $200,000 chemotherapy regimens, anyway.
One in three Americans will hear the words “you have cancer” in their lifetime. Standard treatments — chemo, radiation, targeted therapies — come loaded with brutal side effects, staggering costs, treatment resistance, and outcomes that are, let’s be generous, inconsistent. So when a cheap, well-tolerated alternative starts showing an 84.4% clinical benefit rate, you’d think the medical world would be throwing a parade.
Instead, crickets. Or worse — active suppression.
The Trust Problem
Back in April 2020, when COVID was the boogeyman under every bed, 71.5% of Americans said they had “a lot of trust” in physicians and hospitals. By January 2024, that number had cratered to 40.1%. That’s not a dip. That’s a collapse. And the medical establishment earned every point of that freefall.
They told us to follow the science, then censored anyone who actually did. They mocked cheap, available treatments while fast-tracking expensive ones. They turned healthcare into a loyalty test where the correct answer was always “shut up and comply.”
Trump didn’t tiptoe around this mess — he called it out in real time, took the slings and arrows, and kept pushing for treatment options the so-called experts dismissed. The man was talking about therapeutic possibilities while Fauci was still doing magazine covers.
What the Doctor Said
Dr. McCullough put it plainly:
“This study reveals an exciting new potential that should expand the consideration of Ivermectin and Mebendazole for inclusion in the treatment of multiple cancer types. We urgently need a full-fledged scientific investigation into this class of medications and their impact on cancer treatment.”
Translation: this works, it’s promising, and we need to go bigger. Yesterday.
Real People, Real Results
Judith M. was stage 4, terminal, with metastatic breast cancer throughout her body. After treatment, her PET scan showed no live cancer anywhere. Her words: “The truth is Ivermectin and Mebendazole was a game changer.”
Helen’s daughter had uterine cancer and lungs riddled with cancerous nodules — dime and pea-sized, top to bottom. Two weeks on Ivermectin and Mebendazole later, a physician had to search for a nodule big enough to even biopsy. He found one. A few centimeters wide. At the very bottom of her left lung.
These aren’t statistics. These are mothers and daughters.
The Bottom Line
The Wellness Company is currently the only outfit in the world prescribing U.S. compounded high-dose Ivermectin (25 mg) + Mebendazole (250 mg). You can order a 45-day or 90-day supply, fill out a quick medical intake form, and get it shipped to your door. Use code BBNEWS to save up to $60 off plus free shipping. U.S. residents only.
For years, the establishment told you this drug was worthless — dangerous, even. They lied about its use during COVID, and now the data suggests they may have been sitting on something far bigger. The “horse paste” might just be one of the most important cancer research stories of the decade, and the only people who saw it coming were the ones they tried to silence.
Funny how that keeps happening.
